RecruitingNCT06866782

European Registry of Next Generation Imaging in Advanced Prostate Cancer

Sponsor

Fundacio Puigvert

Enrollment

600 participants

Start Date

Sep 17, 2024

Study Type

OBSERVATIONAL

Conditions

Prostate Cancer Advanced Prostate Cancer Metastatic Prostate Cancer (mPC)

Summary

The RING study is a European registry collecting real-world data on advanced prostate cancer (APC) imaging. It aims to evaluate the role of next-generation imaging (NGI), such as PET/CT and whole-body MRI, in detecting and monitoring the disease compared to conventional imaging. Men aged 18 or older with histologically confirmed prostate cancer are eligible to participate in the study if they require imaging to assess potential metastases, either at diagnosis or after relapse and sign a consent form. Patients will receive standard care with no experimental treatments. Imaging and treatment decisions will follow routine clinical practice. Data will be collected from medical records and analysed for research. This study will help doctors understand when NGI should be used, how it affects treatment decisions, and its impact on patient outcomes.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This European registry study tracks how next-generation imaging techniques (such as PSMA PET scans) are used in men with advanced prostate cancer to detect where the cancer has spread, and follows outcomes over time. **You may be eligible if...** - You are male, 18 or older - You have been confirmed to have prostate cancer by biopsy or pathology - You need imaging to check if your cancer has spread — either at initial diagnosis (high-risk cancer) or because your PSA levels have risen after previous treatment **You may NOT be eligible if...** - You have already had imaging for a different clinical reason not covered by the study protocol - You are unable or unwilling to give informed consent - You are participating in another interventional clinical trial that would interfere with this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTImaging

Imaging will be done according to local protocols and/or guidelines of EAU

Locations(24)

Universitair Ziekenhuis Leuven

Leuven, Belgium

Hospital Center University De Lille

Lille, France

Hospices Civils de Lyon

Lyon, France

University Hospitals Pitié Salpêtrière

Paris, France

Bonn University Hospital

Bonn, Germany

Martini Klinik

Hamburg, Germany

München LMU L MU-University Clinic

Munich, Germany

Urologische Klinik München - Planegg

Planegg, Germany

Universitätsklinik Tübingen

Tübingen, Germany

IRCCS Universit of Bologna

Bologna, Italy

Azienda Ospedaliero-Universitaria Careggi

Florence, Italy

Azienda Ospedaliero-Universitaria Careggi

Florence, Italy

IRCCS Ospedale San Raffaele

Milan, Italy

ERASMUS MC & Franciscus Hospital

Rotterdam, Netherlands

Uniwersytet Jagielloński Collegium Medicum

Krakow, Poland

Fundació Puigvert

Barcelona, Spain

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

Hospital Universitario Reina Sofia

Córdoba, Spain

Hospital Universitario La Paz

Madrid, Spain

Hospital Universitario Ramón y Cajal

Madrid, Spain

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Spain

Hospital Universitario Marqués de Valdecilla

Santander, Spain

Hospital Clínico Universitario de Santiago

Santiago de Compostela, Spain

Skånes universitetssjukhus Malmö

Malmö, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06866782

Related Trials

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

NCT046926751 location

DESTINY-PANTUMOUR04

NCT0712400017 locations

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

NCT0700515433 locations

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

NCT068073593 locations

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

NCT0733644618 locations